115 related articles for article (PubMed ID: 38309250)
1. MiR-182 in Glioma: An insufficiently explored and controversial research area.
Chen LL; Zhao XY
J Neurol Sci; 2024 Mar; 458():122911. PubMed ID: 38309250
[No Abstract] [Full Text] [Related]
2. MiR-124 inhibits cell proliferation, invasion, and migration in glioma by targeting Smad2.
Lv Z; Zhao Y
Int J Clin Exp Pathol; 2017; 10(11):11369-11376. PubMed ID: 31966492
[TBL] [Abstract][Full Text] [Related]
3. MiR-4310 induced by SP1 targets PTEN to promote glioma progression.
Wu Z; Luo J; Huang T; Yi R; Ding S; Xie C; Xu A; Zeng Y; Wang X; Song Y; Shi X; Long H
Cancer Cell Int; 2020 Dec; 20(1):567. PubMed ID: 33327965
[TBL] [Abstract][Full Text] [Related]
4. IL-33 in Atherosclerosis: An Insufficiently Explored and Controversial Research Area.
Ye Y; Chang F; Xu Y
Cardiovasc Drugs Ther; 2024 Jun; 38(3):419-420. PubMed ID: 38294596
[No Abstract] [Full Text] [Related]
5. MicroRNA-92a in Cardiovascular Disease: An Insufficiently Explored and Controversial Research Area.
Cui JZ; Yuan YM; Lin YY
Cardiovasc Drugs Ther; 2024 Jun; 38(3):423-424. PubMed ID: 38038820
[No Abstract] [Full Text] [Related]
6. Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma.
Xiao Y; Zhang L; Song Z; Guo C; Zhu J; Li Z; Zhu S
Med Sci Monit; 2016 Mar; 22():855-62. PubMed ID: 26978735
[TBL] [Abstract][Full Text] [Related]
7. ALKBH5 in Colorectal Cancer: An Insufficiently Explored and Controversial Research Area.
Yang Z; Zhang BL
Gastroenterology; 2023 Dec; 165(6):1581. PubMed ID: 37659670
[No Abstract] [Full Text] [Related]
8. miR-302e Suppresses Glioma Progression by Targeting VEGFA.
Xie Y; Liu X; Hu T; Wang W
Cancer Manag Res; 2020; 12():10965-10974. PubMed ID: 33154675
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 in cancer: An insufficiently explored and controversial research area.
Yang Z
Dig Liver Dis; 2023 Dec; 55(12):1774. PubMed ID: 37673767
[No Abstract] [Full Text] [Related]
10. circ_0008285 Regulates Glioma Progression via the miR-384/HMGB1 Axis.
Yan M; Hu C; Hu Q; Ma H; Lei C; Liu Y
Int J Genomics; 2023; 2023():1680634. PubMed ID: 37575469
[TBL] [Abstract][Full Text] [Related]
11. Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis.
Wei X; Chen D; Lv T; Li G; Qu S
Mol Neurobiol; 2016 Jan; 53(1):163-170. PubMed ID: 25416859
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.
Jiang G; Mu J; Liu X; Peng X; Zhong F; Yuan W; Deng F; Peng X; Peng S; Zeng X
Sci Rep; 2020 Mar; 10(1):4220. PubMed ID: 32144351
[TBL] [Abstract][Full Text] [Related]
13. MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma.
Chen X; Yang F; Zhang T; Wang W; Xi W; Li Y; Zhang D; Huo Y; Zhang J; Yang A; Wang T
J Exp Clin Cancer Res; 2019 Feb; 38(1):99. PubMed ID: 30795814
[TBL] [Abstract][Full Text] [Related]
14. Human marrow stromal cells secrete microRNA-375-containing exosomes to regulate glioma progression.
Deng SZ; Lai MF; Li YP; Xu CH; Zhang HR; Kuang JG
Cancer Gene Ther; 2020 Apr; 27(3-4):203-215. PubMed ID: 30728448
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
Li J; Li Q; Lin L; Wang R; Chen L; Du W; Jiang C; Li R
BMC Neurol; 2018 Aug; 18(1):133. PubMed ID: 30170559
[TBL] [Abstract][Full Text] [Related]
16. microRNA-328 is a favorable prognostic marker in human glioma via suppressing invasive and proliferative phenotypes of malignant cells.
Yuan J; Zheng Z; Zheng Y; Lu X; Xu L; Lin L
Int J Neurosci; 2016; 126(2):145-53. PubMed ID: 25562367
[TBL] [Abstract][Full Text] [Related]
17. Author's Reply: "NRF2 in cancer: An insufficiently explored and controversial research area".
Barone M; Polimeno L
Dig Liver Dis; 2023 Dec; 55(12):1775. PubMed ID: 37858513
[No Abstract] [Full Text] [Related]
18. MicroRNA-145 in Cardiovascular Disease: an Insufficiently Explored and Controversial Research Area.
Xu Y; Fan Y; Miao C
Cardiovasc Drugs Ther; 2023 Aug; 37(4):615-616. PubMed ID: 36194353
[No Abstract] [Full Text] [Related]
19. BRG1 in cancer: An insufficiently explored and controversial research area.
Zhang J; Zhang HL; Yan WC; Sun HL
Dig Liver Dis; 2022 Dec; 54(12):1734. PubMed ID: 35999135
[No Abstract] [Full Text] [Related]
20. MicroRNA-19a in cardiovascular disease: An insufficiently explored and controversial research area.
Wang Y; Zhang W; Dong F
Int J Cardiol; 2022 Jan; 347():59. PubMed ID: 34767899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
